home / stock / mvrbf / mvrbf quote
Last: | $0.82 |
---|---|
Change Percent: | 0.0% |
Open: | $0.82 |
Close: | $0.82 |
High: | $0.82 |
Low: | $0.82 |
Volume: | 1,760 |
Last Trade Date Time: | 02/01/2023 09:30:39 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.82 | $0.82 | $0.82 | $0.82 | $0.82 | 1,760 | 02-01-2023 |
$0.74 | $0.74 | $0.74 | $0.74 | $0.74 | 1,000 | 12-07-2022 |
$0.68 | $0 | $0.68 | $0 | $0 | 3,000 | 12-05-2022 |
$0.68 | $0.68 | $0.68 | $0.68 | $0.68 | 200 | 10-13-2022 |
$0.7 | $0.7 | $0.7 | $0.7 | $0.7 | 1,000 | 08-29-2022 |
$0.7 | $0.7 | $0.7 | $0.7 | $0.7 | 1,500 | 08-25-2022 |
$0.73 | $0.73 | $0.73 | $0.73 | $0.73 | 2,000 | 08-24-2022 |
$0.9 | $0.9 | $0.9 | $0.9 | $0.9 | 4,000 | 02-11-2022 |
$1.04 | $1.04 | $1.04 | $1.04 | $1.04 | 200 | 01-11-2022 |
$1.12 | $1.05 | $1.12 | $1.12 | $1.05 | 9,500 | 01-03-2022 |
$1.24 | $1.24 | $1.24 | $1.24 | $1.24 | 5,000 | 11-22-2021 |
$1.24 | $1.24 | $1.24 | $1.24 | $1.24 | 1,000 | 11-18-2021 |
$1.2 | $1.2 | $1.2 | $1.2 | $1.2 | 1,000 | 09-21-2021 |
$1.2205 | $1.2205 | $1.2205 | $1.2205 | $1.2205 | 200 | 09-16-2021 |
$1.3 | $1.3 | $1.3 | $1.3 | $1.3 | 765 | 09-10-2021 |
$1.19 | $1.19 | $1.19 | $1.19 | $1.19 | 875 | 08-16-2021 |
$1.12 | $1.12 | $1.12 | $1.12 | $1.12 | 1,000 | 08-06-2021 |
$1 | $1 | $1 | $1 | $1 | 250 | 07-30-2021 |
$1.09 | $1.09 | $1.09 | $1.09 | $1.09 | 250 | 07-28-2021 |
$1.04 | $1.04 | $1.04 | $1.04 | $1.04 | 1,111 | 07-23-2021 |
News, Short Squeeze, Breakout and More Instantly...
Medivir B Company Name:
MVRBF Stock Symbol:
OTCMKTS Market:
MEDIVIR AB - INTERIM REPORT JANUARY - JUNE 2022 PR Newswire STOCKHOLM , Aug. 19, 2022 /PRNewswire/ -- The clinical development of fostrox remains the focus April - June Financial summary for the quarter Net turnover amoun...
Birinapant clinical study initiated by IGM Biosciences PR Newswire STOCKHOLM , Nov. 4, 2021 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR ) today announced that IGM Biosciences, Inc. has initiated its clinical study in solid cancers with birinapant (...
Medivir to present at the ProHearings shared Capital Markets Day PR Newswire STOCKHOLM , Oct. 11, 2021 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the ProHearings shared Capital Markets Day, Octo...